Delivery Order SPE2DB20D3103-SPE2DB24FP5S2

Award Date 7/17/24
Potential Completion Date 7/18/24
Potential Value $14K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $34,901.76, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order that provides the DLA with TRIUMEQ 600-50-300 MG TABLET, a pharmaceutical product, under a Firm Fixed Price pricing structure. The contract has an ultimate completion date of November 7, 2024. This contract award is associated with a larger Indefinite Delivery...
This federal contract award, valued at $40,529.61, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the delivery of TRIUMEQ 600-50-300 MG TABLET UU 30S, a pharmaceutical product, to support military healthcare programs. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $6,733.24, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TRIUMEQ 600-50-300 MG TABLET, a pharmaceutical product, with a completion date of January 8, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between Amerisourcebergen and the...
This federal contract award, valued at $48,931.14, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and an Ultimate Completion Date of January 14, 2025. The award is for the supply of TRIUMEQ 600-50-300 MG TABLET, a pharmaceutical product. This contract is not designated with a Set-Aside requirement, indicating open...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $13,039.74, and has an ultimate completion date of January 21, 2025. The contract is for the supply of TRIUMEQ 600-50-300 MG TABLET, a pharmaceutical product. This award is part of a larger Indefinite Delivery Contract (IDC) held by...
This contract award, valued at $47,279.67, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a firm fixed-price delivery order for the supply of TRIUMEQ 600-50-300 MG TABLET UU 30S, a pharmaceutical product, with a period of performance through December 11, 2024. The award appears to be part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,270.42 firm fixed-price delivery order is for TRIUMEQ 600-50-300 MG TABLET, a pharmaceutical product, with a completion date of January 15, 2025. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop Support Medical. This IDC serves as a primary...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $26,963.19, is for the delivery of TRIUMEQ 600-50-300 MG TABLET UU 30S, a pharmaceutical product. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,009.88 Firm Fixed Price delivery order contract covers the supply of TRIUMEQ 600-50-300 MG TABLET UU 30S, a pharmaceutical product. The contract has an ultimate completion date of October 28, 2024. This award appears to be a task order placed against a larger Indefinite Delivery Contract (IDC) held by...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $13,039.74 firm fixed-price delivery order is for TRIUMEQ 600-50-300 MG TABLET prescription medication. The contract has an ultimate completion date of January 3, 2025. The award is associated with a larger Indefinite Delivery Contract (IDC) worth $999,999,999 that Amerisourcebergen holds with the DLA Troop Support...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB24FP5S2
    Delivery Order

This federal contract award, valued at $13,538.92, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for TRIUMEQ 600-50-300 MG TABLET UU 30S, a pharmaceutical product, and has an ultimate completion date of July 18, 2024.

The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 5/17/25, 9:47 AM